Utah Medical Products
UTMD
114 hedge funds and large institutions have $160M invested in Utah Medical Products in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 10 closing their positions.
71% more capital inflows, than outflows
Capital inflows: $8.69M | Capital outflows: $5.08M
41% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 34
2.06% more ownership
Funds ownership: 70.74% → 72.79% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 119 → 114 (-5)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brandes Investment Partners
La Jolla,
California
|
+$1.72M |
| 2 |
Morgan Stanley
New York
|
+$1.39M |
| 3 |
BlackRock
New York
|
+$1.07M |
| 4 |
Quantinno Capital Management
New York
|
+$879K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$314K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$801K |
| 2 |
Renaissance Technologies
New York
|
-$552K |
| 3 |
Huber Capital Management
El Segundo,
California
|
-$459K |
| 4 |
Millennium Management
New York
|
-$420K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$364K |
UTMD Hedge Fund Activity: Q2 2026 in Review
114 of the 8,362 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2026, worth a combined $160M — up 14% from $140M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of UTMD and 7 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 48 added.
The largest buyer was Brandes Investment Partners, adding an estimated $1.72M. The largest seller was Geode Capital Management, cutting an estimated $801K.
- 114 institutional investors held Utah Medical Products (UTMD) as of Q2 2026, down from 119 in Q1 2026.
- Funds reported $160M of Utah Medical Products stock for Q2 2026, up 14% quarter-over-quarter.
- 7 funds opened new Utah Medical Products positions in Q2 2026 and 10 closed out, a net change of -3 holders.
- The largest Utah Medical Products buyer in Q2 2026 was Brandes Investment Partners, an estimated $1.72M added.
- The largest Utah Medical Products seller in Q2 2026 was Geode Capital Management, an estimated $801K sold.
Based on aggregated 13F filings for Q2 2026.